Serum Institute of India leads cross-sector Indian investments into UK4 min read 05 May 2021, 08:17 PM IST
The Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors such as healthcare, biotech and software services to announce significant investment plans in the UK
It was also revealed that SII has started phase one trials in the UK of a nasal vaccine
The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business and set up a new sales office creating a large number of jobs, Downing Street has announced as part of plans for a GBP 1 billion India-UK Enhanced Trade Partnership creating around 6,500 jobs in Britain.
Select your Category